Advertisement

Index by author

November 01, 1982; Volume 10,Issue 6

  1. Madelmont, J C

    1. Main metabolites of 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha, beta-D-ribofuranosyl]-1-nitrosourea and 1-(2-chloroethyl)-3-(2',3', 4'-tri-O-acetyl-alpha, beta-D-ribopyranosyl)-1-nitrosourea in rats.
      J C Madelmont, M F Moreau, D Godeneche, J Duprat, R Plagne and G Meyniel
      Drug Metabolism and Disposition November 1982, 10 (6) 662-666;

  2. Maguire, J H

    1. 5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
      J H Maguire, T C Butler and K H Dudley
      Drug Metabolism and Disposition November 1982, 10 (6) 595-598;

  3. Martin, B R

    1. Disposition of phencyclidine in mice after smoke exposure.
      A S Freeman and B R Martin
      Drug Metabolism and Disposition November 1982, 10 (6) 680-684;
    2. In vitro metabolism of 1-phenyl-1-cyclohexene, a pyrolysis product of phencyclidine.
      B R Martin, B B Bailey, H Awaya, E L May and N Narasimhachari
      Drug Metabolism and Disposition November 1982, 10 (6) 685-689;

  4. May, E L

    1. In vitro metabolism of 1-phenyl-1-cyclohexene, a pyrolysis product of phencyclidine.
      B R Martin, B B Bailey, H Awaya, E L May and N Narasimhachari
      Drug Metabolism and Disposition November 1982, 10 (6) 685-689;

  5. Meyniel, G

    1. Main metabolites of 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha, beta-D-ribofuranosyl]-1-nitrosourea and 1-(2-chloroethyl)-3-(2',3', 4'-tri-O-acetyl-alpha, beta-D-ribopyranosyl)-1-nitrosourea in rats.
      J C Madelmont, M F Moreau, D Godeneche, J Duprat, R Plagne and G Meyniel
      Drug Metabolism and Disposition November 1982, 10 (6) 662-666;

  6. Middleditch, B S

    1. Urinary bivalent sulfur metabolites of phenanthrene excreted by the rat and guinea pig.
      K Lertratanangkoon, M G Horning, B S Middleditch, W S Tsang and G W Griffin
      Drug Metabolism and Disposition November 1982, 10 (6) 614-623;

  7. Miners, J O

    1. Theobromine metabolism in man.
      J O Miners, J Attwood and D J Birkett
      Drug Metabolism and Disposition November 1982, 10 (6) 672-675;

  8. Moreau, M F

    1. Main metabolites of 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha, beta-D-ribofuranosyl]-1-nitrosourea and 1-(2-chloroethyl)-3-(2',3', 4'-tri-O-acetyl-alpha, beta-D-ribopyranosyl)-1-nitrosourea in rats.
      J C Madelmont, M F Moreau, D Godeneche, J Duprat, R Plagne and G Meyniel
      Drug Metabolism and Disposition November 1982, 10 (6) 662-666;

  9. Moustafa, M A

    1. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
      M Claesen, M A Moustafa, J Adline, D Vandervorst and J H Poupaert
      Drug Metabolism and Disposition November 1982, 10 (6) 667-671;

  10. Muhlebach, S

    1. Pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. I. Effects of restricting food intake two weeks after administration of 6-CB.
      P A Wyss, S Mühlebach and M H Bickel
      Drug Metabolism and Disposition November 1982, 10 (6) 657-661;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement